Calvin Sandrainsider trades
In SEC Form 4 filings, Calvin Sandra is listed as SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics, Inc. (TVTX). In the last 90 days, Calvin Sandra sold $335K of Travere Therapeutics, Inc. (TVTX) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | SVP, CHIEF ACCOUNTING OFFICER | 9 | Sep 17 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 2,500 | $27.50 | $68,750 | 44,853 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 1,250 | $22.40 | $28,000 | 46,103 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 1,625 | $20.46 | $33,248 | 47,728 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 4,275 | $62.14 | Sale −$265,627 | 43,453 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 800 | $62.85 | Sale −$50,278 | 42,653 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 300 | $63.66 | Sale −$19,099 | 42,353 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 2,500 | $27.50 | $68,750 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 1,250 | $22.40 | $28,000 | 3,750 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 1,625 | $20.46 | $33,248 | 17,875 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.